Neridronate (sodium)
Neridronate sodium is a bone resorption factors inhibitor. Neridronate sodium can be used in research on diseases such as metabolic bone disease and musculoskeletal pain[1].
Product Specifications
CAS Number
80729-79-9
UNSPSC
12352211
Target
Others
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
NCCCCCC(P(O)(O[Na])=O)(O)P(O)(O)=O
Molecular Formula
C6H16NNaO7P2
Molecular Weight
299.13
References & Citations
[1]Iolascon G, Moretti A. The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain. Int J Mol Sci. 2022 Jun 22;23 (13) :6921.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880009-500 1x 500 µL
MART-1 / Melan-A (M2-7C10), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940960-500 1x 500 µL
MUC1 / EMA / CD227 (Epithelial Marker) (rMUC1/960), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470261-500 1x 500 µL
CD66 (CEA) (C66/261), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details